Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
SOPHiA GENETICS
SOPH
$678M
| $819K | ﹤0.01% |
141,992
-48,018
| -25% | -$244K |
2022 Q4
14 quarters
|
|
1202
DELISTED
Webster Financial
WBS
| $818K | ﹤0.01% |
10,701
-9,505
| -47% | -$691K |
2013 Q2
52 quarters
|
|
1203
Community Health Systems
CYH
$338M
| $813K | ﹤0.01% |
243,293
+10,214
| +4% | +$30.1K |
2013 Q2
52 quarters
|
|
1204
Donaldson
DCI
$9.6B
| $809K | ﹤0.01% |
9,008
-220
| -2% | -$18.9K |
2013 Q2
52 quarters
|
|
1205
Ingevity
NGVT
$2.59B
| $808K | ﹤0.01% |
10,816
+160
| +2% | +$11.5K |
2024 Q2
8 quarters
|
|
1206
Oshkosh
OSK
$8.53B
| $806K | ﹤0.01% |
5,250
-203
| -4% | -$28.6K |
2013 Q2
52 quarters
|
|
1207
OppFi
OPFI
$499M
| $803K | ﹤0.01% |
80,914
| – | – |
2024 Q3
7 quarters
|
|
1208
Antero Resources
AR
$12.9B
| $799K | ﹤0.01% |
22,742
-29,740
| -57% | -$1.09M |
2021 Q1
21 quarters
|
|
1209
Colgate-Palmolive
CL
$75.7B
| $788K | ﹤0.01% |
8,595
-1,116
| -11% | -$97.6K |
2013 Q2
52 quarters
|
|
1210
Terex
TEX
$6.31B
| $786K | ﹤0.01% |
10,851
+321
| +3% | +$20.1K |
2013 Q2
52 quarters
|
|
1211
National Fuel Gas
NFG
$7.56B
| $783K | ﹤0.01% |
10,138
+230
| +2% | +$19K |
2013 Q2
52 quarters
|
|
1212
Brown & Brown
BRO
$23.1B
| $776K | ﹤0.01% |
12,096
-294,440
| -96% | -$18M |
2013 Q2
52 quarters
|
|
1213
Zevra Therapeutics
ZVRA
$610M
| $776K | ﹤0.01% |
54,111
+11,916
| +28% | +$132K |
2025 Q2
4 quarters
|
|
1214
Encompass Health
EHC
$13.4B
| $775K | ﹤0.01% |
7,664
-334
| -4% | -$34.6K |
2018 Q1
33 quarters
|
|
1215
Flowserve
FLS
$10B
| $757K | ﹤0.01% |
10,212
-9,796
| -49% | -$745K |
2016 Q2
40 quarters
|
|
1216
Park Hotels & Resorts
PK
$3.34B
| $757K | ﹤0.01% |
53,091
+28,201
| +113% | +$345K |
2019 Q3
27 quarters
|
|
1217
American International
AIG
$42.8B
| $756K | ﹤0.01% |
10,138
+1,936
| +24% | +$147K |
2013 Q2
52 quarters
|
|
1218
Schwab US Dividend Equity ETF
SCHD
$120B
| $752K | ﹤0.01% |
23,700
| – | – |
2024 Q3
7 quarters
|
|
1219
Cullen/Frost Bankers
CFR
$9.8B
| $750K | ﹤0.01% |
4,852
-172
| -3% | -$24.4K |
2013 Q2
52 quarters
|
|
1220
Gold Fields
GFI
$29.3B
| $748K | ﹤0.01% |
22,272
+1,401
| +7% | +$58.3K |
2022 Q1
17 quarters
|
|
1221
Bread Financial
BFH
$3.93B
| $747K | ﹤0.01% |
6,894
+1,074
| +18% | +$96.5K |
2013 Q2
52 quarters
|
|
1222
Perspective Therapeutics
CATX
$131M
| $740K | ﹤0.01% |
217,023
-5,119
| -2% | -$19.3K |
2025 Q1
5 quarters
|
|
1223
Medifast
MED
$136M
| $739K | ﹤0.01% |
69,605
+5,684
| +9% | +$65.6K |
2013 Q2
52 quarters
|
|
1224
LyondellBasell Industries
LYB
$22.2B
| $735K | ﹤0.01% |
13,968
+150
| +1% | +$10.4K |
2013 Q2
52 quarters
|
|
1225
Riot Platforms
RIOT
$4.81B
| $733K | ﹤0.01% |
26,770
+26,589
| +14,690% | +$599K |
2025 Q2
4 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.